Weight
Hip arthroscopy may not be best option for older people with arthritis, says study
A new study has found that arthroscopic surgery, a less invasive procedure than total hip replacement, may not be the best option for people over 60 who have arthritis.
Researchers at Hospital for Special Surgery (HSS) in Manhattan, New York, analysed patient databases from California and Flora, to see how many patients ended up needing a hip replacement within two years of arthroscopic hip surgery. Continue reading
People endure pain of arthritis for years before seeking help, says survey
A new survey conduced by Arthritis Care has found that people are enduring years of pain before seeking help for arthritis. In the UK wide survey, in which 2000 people took part, it showed that 16% waited over one year, while 28% waited over two years before taking action. Continue reading
Roadmap launched by BSR to improve care for people with rare rheumatic and musculoskeletal conditions
The British Society for Rheumatology (BSR) has today launched a report setting out a programme of work to enhance care for people with rare rheumatic and musculoskeletal conditions.
This new roadmap highlights the need for a collaborative approach to improve outcomes in rare rheumatic and musculoskeletal diseases and builds on a national workshop which was hosted by the BSR in November 2015. The workshop brought together a range of stakeholders to help raise the priority of rare rheumatic and musculoskeletal conditions and improve patient care. Continue reading
New study says young arthritis patients have unique concerns about treatment
A new study funded by Arthritis Research UK indicates that teens and young adults with inflammatory arthritis see treatment as presenting both an opportunity and a threat to their desire to lead a ‘normal’ life. They describe a wide range of consequences—physical, emotional, social, and vocational—arising from their treatment. Continue reading
Stem cell therapy could halve deaths from heart failure, says study
A new study suggests that end-stage heart failure patients with stem cells harvested from their own bone marrow experienced 37% fewer cardiac events, including death and admission to hospital.
The findings of the study, which were presented at the 2016 American College of Cardiology Conference and published in The Lancet, have been seen as a major breakthrough for regenerative medicine. In the largest trial ever conducted, doctors have shown that even the most serious cases of heart failure can be repaired using stem cells from a patient’s own bone marrow. Continue reading
